Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

CNN correspondent Donie O’Sullivan is pushing back against progressive critics who rip journalists for “platforming” and “humanizing” supporters of Donald Trump and believers in ...

O’Sullivan’s quest for an eighth Crucible title ended abruptly with a 17-7loss to Zhao Xintong. The Chinese star dominated the match, winning all eight frames in the morning session and ...

When I stopped attending my Latter-day Saint ward in 2014, I never really had any intention of going through the formal process of coordinating with corporate to cancel my relationship with God.

Eagles cornerback Eli Ricks stirred controversy during the team's White House visit by publicly expressing his admiration for Ivanka Trump on social media. His tweets, complimenting her appearance ...

In JPMorgan's view, CVS's move "will likely impact only a small portion of Eli Lilly's Zepbound business," and the bank therefore believes Lilly stock will still outperform the market. Investment ...

OXFORD — The New York Giants have given Ole Miss football quarterback Jaxson Dart a chance to break more of Eli Manning's records. The Giants selected Dart with the No. 25 pick in the first ...

There are two ways to look at Ronnie O’Sullivan’s stumble into the semi-finals of the World Snooker Championship. The first, to which O’Sullivan evidently subscribes, is that his erratic ...

Eli Lilly (NYSE: NYSE:LLY) is set to report its first-quarter earnings on Thursday, May 1st, before the market opens. Analysts expect the drugmaker to earn $3.46 (+34.1% Y/Y) on revenue of $12.72B ...

(Bloomberg) -- Investment firm Sullivan Street Partners is nearing a deal for British engineering group Senior Plc’s aerostructures unit, which supplies components to Airbus SE and Boeing Co ...

Positive results for Eli Lilly's new diabetes and weight-loss drug have recently boosted its stock price. Data from several studies on the GLP-1 drug are expected to come out this year.